Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€69.50
29.04.24
€100.00
31.03.26
-0.75%
03.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.04.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-2.00%
27.04.24

Could be worthwhile Investment >10% per year
Global_Player 
25.04.24 50%
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€2.68
24.04.24
-
24.04.25
4.63%
26.04.24

Could be worthwhile Investment >10% per year
Vassago1 
24.04.24 50%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.49
23.04.24
€3.00
23.04.25
-8.41%
27.04.24

Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
skatcup 
23.04.24 80%
buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.75
15.04.24
€3.00
31.10.25
-
15.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 60%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.91
08.04.24
€3.00
08.04.25
-21.66%
27.04.24

Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Traumtanz 
08.04.24 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€66.50
07.04.24
-
07.04.25
0.75%
14.04.24

Could be very worthwhile Investment >20% year
Vassago1 
07.04.24 50%
buy
Cal-Maine Foods Inc.

Start price
Target price
Perf. (%)
€55.84
04.04.24
-
04.04.25
2.94%
13.04.24

Finanzoo 
04.04.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.11
02.04.24
-
02.04.25
-38.74%
16.04.24

Could be very worthwhile Investment >20% year
thomasw 
02.04.24 50%
buy
BioXcel Therapeutics Inc

Start price
Target price
Perf. (%)
€2.44
02.04.24
-
02.04.25
14.60%
13.04.24

Could be worthwhile Investment >10% per year
melinda 
02.04.24 10%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.14
02.04.24
-
02.04.25
-28.14%
13.04.24

Could be worthwhile Investment >10% per year
melinda 
02.04.24 10%
sell
Coeur Mining Inc.

Start price
Target price
Perf. (%)
€3.88
02.04.24
€3.00
02.04.25
15.95%
13.04.24

Probably not worthwhile Investment
High valuation
EBIT decline/stagnation expected
Revenue decline/stagnation expected
kostojunior 
02.04.24 0%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.60
02.04.24
-
02.04.25
-48.88%
13.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
02.04.24 0%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.64
28.03.24
-
28.03.25
-40.27%
31.03.24

Risky Investment
Vassago1 
28.03.24 50%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.55
28.03.24
-
28.03.25
-38.27%
30.03.24

Could be worthwhile Investment >10% per year
daimler1 
28.03.24 50%
sell
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.88
26.03.24
-
26.03.25
-18.09%
31.03.24

Risky Investment
Vassago1 
26.03.24 50%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.57
21.03.24
-
21.03.25
-38.64%
31.03.24

Could be very worthwhile Investment >20% year
bundfuture 
21.03.24 50%
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€16.94
19.03.24
€22.00
19.03.25
14.24%
30.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Some uniques
Risky balance sheet
skatcup 
19.03.24 80%
buy
Super Micro Computer

Start price
Target price
Perf. (%)
€828.60
19.03.24
€900.00
19.03.25
18.14%
30.03.24

Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Capable Management
Low dividend yield expected
skatcup 
19.03.24 80%
sell
Super Micro Computer

Start price
Target price
Perf. (%)
€973.00
18.03.24
€666.00
18.03.25
0.61%
30.03.24

Probably not worthwhile Investment
High valuation
Low dividend yield expected
negative Cash Flow expected
kostojunior 
18.03.24 0%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
18.03.24
-
18.03.25
2.26%
30.03.24

Could be worthwhile Investment >10% per year
Wolf_of_WS 
18.03.24 50%
sell
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
17.03.24
€0.30
30.11.25
76.96%
28.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€10.20
17.03.24
€16.00
30.06.26
-8.82%
19.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
16.03.24
€2.00
16.03.25
2.26%
30.03.24

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
mixitrader 
16.03.24 50%
buy
Chromadex Corp

Start price
Target price
Perf. (%)
€2.22
16.03.24
€4.00
16.03.25
53.15%
30.03.24

EBIT decline/stagnation expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
mixitrader 
16.03.24 50%